Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Observational Pilot Study of Sevoflurane Sedation in ARDS Patients
jRCTs051220017Suspended
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sevoflurane in acute respiratory distress syndrome (ARDS). Primary endpoint: Change in tidal volume at 6 hours. Started Jan 2025; status: suspended.
02
Drugs
sevoflurane
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on jRCTs051220017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051220017.